O
We are thrilled that you are here, and we hope this is the start of many more
successful IBMSC- ati
visionaries, leaders, and “movers and shakers” across Government, Industry,
ati
tin
tioate with our partners – YOU. These
titic
important than ever amidst global unrest, supply chain instability, and inevitable
tiose ptions
diverse, agile, public health supply chain through Industry partnerships.
tititio
and preparedness posture.
tio
ti
tietinue
Management and Supply
Sincerely,
Arlene Joyner
Deputy Assistant Secretary
Director, of Industrial Base Management
and Supply ti
2
Agenda
8:50 AM
9:00 AM
9:20 AM
10:00 AM
10:20 AM
Welcome Addressptiation
Industry Partner Reflection: tion
Keynote Address and Fireside Chat:
Arlene Joyner, Deputy Assistant Secretary (DAS), Director of IBMSC
Building and Preserving a Resilient Medical Industrial Base: Arlene Joyner, DAS, Director of IBMSC
DPA-ERA: Accelerate, Expand, and Preserve the Public Health Supply Chain (Collaborative Discussion):
tionities-ERA)
10:50 AM BREAK
11:00 AM
11:30 AM
ASPR Contracting: PromotingPublic-Private Partnership through Acquisition Excellence (Collaborative
Discussion): ting ctivity,
The BioMap-Consortium: Strategic Partnerships (Collaborative Discussion): Brooke Luck, BARDA
12:00 PM LUNCH
1:00 PM
1:15 PM
Address from Nikki Bratcher-Bowman, ating
HHS ASPR
External Partners Panel
2:00 PM
• ctingations
• tiansenational Economic Council, White House
• ation
• Jason Bolton, Senior Trade and Industry Analyst, Bureau of Industry and Security, Dept. of Commerce
• Sharon Arnold, Supply Chain Resilience and Shortages Coordinator, HHS/ASPE
• ciation
Breakout Session 1
• OptizationEnabling a Resilient Industrial Base. (Wayland Coker)
• vationsPharmaceutical
2:50 PM
BREAK
3:00 PM Breakout Session 2
• Supply Chain Optimization: Supporting Domestic Manufacturing: A Government-Industry Working
Session. (Wayland Coker)
• Enabling Innovations and Technology: Supply Chain Risks and Agile Manufacturing-Future of On-
Shoring, an Industry Perspective. (Joe Hamel)
• Critical Medical Equipment: Strategic Vision for PPE and Medical Equipment Preparedness. (Jesse
Hawkins)
• Testing and Diagnostics: Overcoming Challenges and Barriers to Facilitate Collaboration: Sharing
Essential Resources, Expertise and Data to Combat Future Pandemics
3:50 PM BREAK
4:00 PM Summary and Closing Remarks: Arlene Joyner, DAS, Director of IBMSC
3
Supply Chain Risks and Agile Manufacturing-Future of On-Shoring, a Government Perspective. (Joe Hamel)
• Critical Medical Equipment: Strategic Vision for PPE and Medical Equipment Preparedness. (Jesse
Hawkins)
• Testing and Diagnostics: Pivoting Toward Preparedness in a Threat Agnostic Landscape: Optimizing
Capacity, Scalability and Flexibility for Unknown Demand. (Matt Humbard, PhD)
Dawn O’Connell, Assistant Secretary for Preparedness and Response, U.S. Department of Health and
Human Services (HHS)
s and Response within HHS.
dminstration
organizatonnationpreventing
responding to, and recovering fro-made and naturally occurring
disasters.
organizationactivities
ction civilian
ation
ID-
litionation
tion-based stakeholders, tities
tary Sebelius at HHS
during the Obama-ation-mestic
ctioushe worked
ational
ationation
rbilt University and a Juris Doctor from Tulane University School of Law. She is an avid runner, and lives in Washington,
DC with her husband Ben and two daughters, Frannie and Maddie.
Nikki Bratcher-Bowman, Principal Deputy Assistant Secretary and Chief Operating Officer, HHS
Administration for Strategic Preparedness and Response (ASPR)
Guest Speaker Biographies
Mrs. Nikki Bratcher-Bowman is the Principal Deputy Assistant Secretary for Preparedness and
ating
Mrs. Bratcher-ctingtion
time
continued-anti
uticstional
hard-tinuing
countermeasures needed to respond to the pandemic.
Mrs. Bratcher-tiontiontionstions
strategy, budget, tion tive
Intergovernmental and Ex
tionilities
itionsmation
ationizations
ationptimtiontional tiveness
Mrs. Bratcher-
itionsating
putetion Lationsations
ativeationship-ctiveulti- audience communicator,
ations
Mrs. Bratcher-ition
- one of the highest honors given at HHS. Mrs. Bratcher-Bowman is a
utivetituteUniversity
4
Dean Kamen, Founder, DEKA Research & Development Corporation
Dean Kamen is an tirel
roles as inventor and advocate are intertwined—
cticalation
doing to change the culture of the United States.
vative
ontitillollege
lties
manufacture and market the pumps. Then,
ption
efftivepatients
ation
rationlop
internally tions a
national
atients
paration
Hologic Inc.) ThinPrep® Pap Test. Kamen-led DEKA teams haitical
System, an
extracorporeal photophereisis device marketed by Therakos, a unit of Johnson & Johnson, for treatment of T-Cell
hetic
ation
C.R. Bard, t
he CrownTM stent, an improvement to the original Palmaz-Schatz stent, for Johnson & Johnson, the iBOTTM
mobility de
vice, and the Segway® Human Transporter.
ational
nitionention medical care worldwide, and
ative ative
tio-MIT Prize in 2002 and was
ational Institute
national international organizations
addition
pirationcognition
organizationmotivatingati
ti
-changing FIRST programs gain access to exclusive
scholarships, iticti
5
IBMSC Leadership & Offices
Arlene Joy
ner
Deputy As
sistant Secretary
Director, Office of Industrial Base Management and Supply Chain HHS
Administration for Strategic Preparedness and Response
Ms. Arlene Joyner is the Director of the Industrial Base Management and Supply Chain for the HHS
ProtectiveTesting Diagnostics
Optimization
Ms. eutical
utical
Infrastructure (PCI) Department within the Biomedical Advanced Research and Development
to joining ASPR, Ms. Joyner worked for six years aAuditing
Operations
Operations
Jesse Hawkins, Director, Critical Medical Equipment (CME)
-riticalvulnerabilities
particularly timaterials production capabilities
These challenges underscore the importance of enhancing supply chain resilience to prevent future
escalating dlogistical emergencies,
CME plapatients
ogistica
-
identified vulnerabilities
implementing strategicnitiatives
ti
Paige Ezernack, Director, Defense Production Act and Emergency Response Authorities (DPA-ERA)
The DPA--egislative
activitiesfunctions
The DPA-uthorities
ssential uthoritiesegislative
respond to, public health emergencies li-
identify
6
Actingvations
ptiti
The role of the SCO office is to create a program of activity that seeks the most vulnerable
healthcare and public health supply chains within U.S. and identify courses of action to
mitigate risks of disruption, lessen supply chain vulnerabilities, and increase our national
medical supply chain resilience.
SCO’s efforts help ensure national HPH sector capacities are preserved, economically viable,
resistant to disruption, and kept competitive in the global marketplace so that these
producers/distributors are ready to respond to the next emergency when called upon.
stiti
The Covid-
health industrial base is to ensure the health and security of the country. ASPR focuses on
tir
tisti
supplies for biological threats that endanger tististi
are vital part of this mission.
maintaining a
stiati through the
tiitinti
seeks ldtiintiti
tiortiistiti
industry partners.
7
The EIT office is a component of IBMSC that significantly contributes to strengthening the Domestic
U.S. manufacturing capabilities and ensuring resilient supply chain for public health emergencies.
EIT leads the efforts to enable, engage and enhance domestic supplies of and improved access to
critical drug substances and drug products.
The EIT Office advances the development and deployment of platform technology that 1) enables
on-demand, continuous cGMP compliant production of pharmaceuticals, and 2) enables distributed
on-demand production of cGMP compliant supportive care fluids. Continuing innovation,
development, and commercial deployment of these platforms will enable distributed domestic drug substance and drug
product manufacturing. At the same time, these platforms will help strengthen supply chain resilience, grow the
bioeconomy, and deploy increasingly renewable and sustainable pharmaceutical resources capable of immediately
responding to surges in demand caused by public health emergencies.
Summit meeting documents and video recordings will be posted online:
aspr.hhs.gov/IBMSC/IndustrySummit
Thank you for aending IBMSC’s inaugural Industry Summit!
We hope to see you next year.
Let’s keep the conversaons going! Request a meeng with IBMSC through IBx Connect today
to share your product’s potenal to address health security challenges.
Industrial Base Expansion (IBx) Connect
Industrial Base Expansion (IBx) Connect is used to coordinate tion
academia, and the
private sector. Our goal is to work with the private sector on novel solutions and
practices for response and recovery operations and bring them to life.
aspr.hhs.gov/IBxConnect
IBx Connect meengs are for Market Research purposes only and are not considered submissions for potenal funding.
